• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FGFR抑制剂NVP-BGJ398通过激活半胱天冬酶依赖性途径以及非半胱天冬酶依赖性凋亡诱导非小细胞肺癌细胞死亡。

The FGFR Inhibitor NVP-BGJ398 Induces NSCLC Cell Death by Activating Caspase-dependent Pathways as well as Caspase-independent Apoptosis.

作者信息

Göke Antonia, Göke Rüdiger, Ofner Andrea, Herbst Andreas, Lankat-Buttgereit Brigitte

机构信息

Research Unit of Gastroenterology, Center for Tumor and Immunobiology, Faculty of Medicine, University of Marburg, Marburg, Germany.

Diabetes Center Marburg, Marburg, Germany.

出版信息

Anticancer Res. 2015 Nov;35(11):5873-9.

PMID:26504010
Abstract

BACKGROUND

Fibroblast growth factor receptors are expressed in diverse cell types. They play a critical role in tumor development. Their activation promotes cell-cycle progression, angiogenesis, and cell survival by induction/suppression of the expression of proteins involved.

MATERIALS AND METHODS

Non-small cell lung cancer (NSCLC) cells (line H1581) were treated with NVP-BGJ398 to evaluate effects on growth by western blot, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide assay and cell-cycle analysis.

RESULTS

NVP-BGJ398 induced cell death in H1581 cells by activating caspase-dependent mitochondrial and non-mitochondrial pathways. Caspase-independent apoptosis was also activated. Cells were found to be arrested in the G0/G1 phase. Furthermore, the expression of the tumor-suppressor gene programmed cell death 4 (PDCD4) was up-regulated with suppression of angiopoietin 2 (ANG2). This represents an additional mechanism by which NVP-BGJ389 inhibits tumor growth.

CONCLUSION

Various pathways induce apoptosis in NSCLC cells by employing NVP-BGJ398. These data reflect the potential of cancer treatment utilizing small FGFR inhibitors.

摘要

背景

成纤维细胞生长因子受体在多种细胞类型中表达。它们在肿瘤发展中起关键作用。其激活通过诱导/抑制相关蛋白的表达促进细胞周期进程、血管生成和细胞存活。

材料与方法

用NVP-BGJ398处理非小细胞肺癌(NSCLC)细胞(H1581细胞系),通过蛋白质印迹法、3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐法和细胞周期分析评估对生长的影响。

结果

NVP-BGJ398通过激活半胱天冬酶依赖性线粒体和非线粒体途径诱导H1581细胞死亡。半胱天冬酶非依赖性凋亡也被激活。发现细胞停滞于G0/G1期。此外,肿瘤抑制基因程序性细胞死亡4(PDCD4)的表达上调,血管生成素2(ANG2)受到抑制。这代表了NVP-BGJ389抑制肿瘤生长的另一种机制。

结论

多种途径通过使用NVP-BGJ398诱导NSCLC细胞凋亡。这些数据反映了利用小分子FGFR抑制剂进行癌症治疗的潜力。

相似文献

1
The FGFR Inhibitor NVP-BGJ398 Induces NSCLC Cell Death by Activating Caspase-dependent Pathways as well as Caspase-independent Apoptosis.FGFR抑制剂NVP-BGJ398通过激活半胱天冬酶依赖性途径以及非半胱天冬酶依赖性凋亡诱导非小细胞肺癌细胞死亡。
Anticancer Res. 2015 Nov;35(11):5873-9.
2
Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.成纤维细胞生长因子受体抑制剂多韦替尼(TKI258)和 NVP-BGJ398 在人子宫内膜癌细胞中的活性。
Mol Cancer Ther. 2013 May;12(5):632-42. doi: 10.1158/1535-7163.MCT-12-0999. Epub 2013 Feb 26.
3
FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor.FGFR 基因突变预测对 NVP-BGJ398(一种选择性泛 FGFR 抑制剂)的敏感性。
Cancer Discov. 2012 Dec;2(12):1118-33. doi: 10.1158/2159-8290.CD-12-0210. Epub 2012 Sep 20.
4
Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.死亡受体调节与塞来昔布诱导人肺癌细胞凋亡
J Natl Cancer Inst. 2004 Dec 1;96(23):1769-80. doi: 10.1093/jnci/djh322.
5
FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers.FGFR1表达水平可预测FGFR1依赖性头颈部鳞状细胞癌对BGJ398的敏感性。
Clin Cancer Res. 2015 Oct 1;21(19):4356-64. doi: 10.1158/1078-0432.CCR-14-3357. Epub 2015 May 26.
6
FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.成纤维细胞生长因子受体抑制剂 BGJ398 和组蛋白去乙酰化酶抑制剂 OBP-801 协同抑制膀胱癌细胞的生长并诱导其凋亡。
Oncol Rep. 2018 Feb;39(2):627-632. doi: 10.3892/or.2017.6127. Epub 2017 Dec 1.
7
Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC.发现 4,6-嘧啶二胺衍生物作为新型双重 EGFR/FGFR 抑制剂,针对 EGFR/FGFR1 阳性 NSCLC。
Eur J Med Chem. 2020 Feb 1;187:111943. doi: 10.1016/j.ejmech.2019.111943. Epub 2019 Dec 5.
8
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression.BGJ398,一种泛 FGFR 抑制剂,克服了 FGFR1 过表达的膀胱癌对紫杉醇的耐药性。
Int J Mol Sci. 2018 Oct 15;19(10):3164. doi: 10.3390/ijms19103164.
9
Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.抑制FGFR信号通路可部分挽救HMWFGF2转基因雄性小鼠的低磷性佝偻病。
Endocrinology. 2017 Oct 1;158(10):3629-3646. doi: 10.1210/en.2016-1617.
10
[Inhibitory Eefects of the novel tyrosine kinase inhibitor BGJ398 against human leukemic cell line KG-1 cells].新型酪氨酸激酶抑制剂BGJ398对人白血病细胞系KG-1细胞的抑制作用
Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):143-147. doi: 10.3760/cma.j.issn.0253-2727.2018.02.013.

引用本文的文献

1
Fibroblast Growth Factor Receptor Inhibitors Decrease Proliferation of Melanoma Cell Lines and Their Activity Is Modulated by Vitamin D.成纤维细胞生长因子受体抑制剂可降低黑色素瘤细胞系的增殖,且其活性受维生素D的调节。
Int J Mol Sci. 2024 Feb 21;25(5):2505. doi: 10.3390/ijms25052505.
2
Biological Significance and Targeting of the FGFR Axis in Cancer.成纤维细胞生长因子受体(FGFR)轴在癌症中的生物学意义及靶向作用
Cancers (Basel). 2021 Nov 13;13(22):5681. doi: 10.3390/cancers13225681.
3
Knockdown of Bcl-2-Associated Athanogene-3 Can Enhance the Efficacy of BGJ398 via Suppressing Migration and Inducing Apoptosis in Gastric Cancer.
敲低 Bcl-2 相关泛素样蛋白 3 能够通过抑制迁移和诱导凋亡增强 BGC-823 对胃癌的疗效。
Dig Dis Sci. 2021 Sep;66(9):3036-3044. doi: 10.1007/s10620-020-06640-5. Epub 2020 Oct 22.
4
(+)-Bornyl -Coumarate Extracted from Stem of Induced Apoptosis and Autophagy in Melanoma Cells.(+)-莰烯 - 香豆酸酯从诱导的黑色素瘤细胞凋亡和自噬中提取。
Int J Mol Sci. 2020 May 25;21(10):3737. doi: 10.3390/ijms21103737.
5
Simvastatin Induces Apoptosis in Medulloblastoma Brain Tumor Cells via Mevalonate Cascade Prenylation Substrates.辛伐他汀通过甲羟戊酸级联异戊二烯化底物诱导髓母细胞瘤脑肿瘤细胞凋亡。
Cancers (Basel). 2019 Jul 17;11(7):994. doi: 10.3390/cancers11070994.
6
Proliferation of poorly differentiated endometrial cancer cells through autocrine activation of FGF receptor and HES1 expression.通过自分泌激活 FGF 受体和 HES1 表达促进低分化子宫内膜癌细胞的增殖。
Hum Cell. 2019 Jul;32(3):367-378. doi: 10.1007/s13577-019-00249-1. Epub 2019 Apr 8.
7
Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models.罗加替尼:一种有效的、选择性的 pan-FGFR 抑制剂,在过表达 FGFR 的临床前癌症模型中具有广泛的抗肿瘤活性。
Int J Cancer. 2019 Sep 1;145(5):1346-1357. doi: 10.1002/ijc.32224. Epub 2019 Mar 13.
8
Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer.Bcl-2 抑制剂增强 FGFR 抑制剂诱导的 FGFR2 突变型子宫内膜癌中线粒体依赖性细胞死亡。
Mol Oncol. 2019 Apr;13(4):738-756. doi: 10.1002/1878-0261.12422. Epub 2019 Jan 18.
9
[Inhibitory Eefects of the novel tyrosine kinase inhibitor BGJ398 against human leukemic cell line KG-1 cells].新型酪氨酸激酶抑制剂BGJ398对人白血病细胞系KG-1细胞的抑制作用
Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):143-147. doi: 10.3760/cma.j.issn.0253-2727.2018.02.013.
10
promotes lung cancer metastasis by increasing epithelial-mesenchymal transition.通过增加上皮-间质转化促进肺癌转移。
Oncotarget. 2018 Jan 9;9(16):12705-12717. doi: 10.18632/oncotarget.24061. eCollection 2018 Feb 27.